|
GPR183 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.45269999998854E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.92329999995733E-06 |
| Normal-vs-Stage2 |
7.439100E-03 |
| Normal-vs-Stage3 |
1.903590E-01 |
| Normal-vs-Stage4 |
2.385000E-01 |
| Stage1-vs-Stage2 |
8.950200E-01 |
| Stage1-vs-Stage3 |
2.115000E-03 |
| Stage1-vs-Stage4 |
2.508200E-01 |
| Stage2-vs-Stage3 |
6.080500E-02 |
| Stage2-vs-Stage4 |
2.234600E-01 |
| Stage3-vs-Stage4 |
8.201400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8354099999951E-05 |
| Normal-vs-AfricanAmerican |
7.177100E-04 |
| Normal-vs-Asian |
9.248600E-01 |
| Caucasian-vs-AfricanAmerican |
8.365800E-01 |
| Caucasian-vs-Asian |
4.037600E-03 |
| AfricanAmerican-vs-Asian |
8.257100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.96160000038348E-07 |
| Normal-vs-Female |
1.068410E-02 |
| Male-vs-Female |
7.242500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.184100E-02 |
| Normal-vs-Extreme_Weight |
2.46680000000055E-05 |
| Normal-vs-Obese |
3.019700E-03 |
| Normal-vs-Extreme_Obese |
5.714300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.718000E-03 |
| Normal_Weight-vs-Obese |
7.749500E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.982600E-01 |
| Extreme_Weight-vs-Obese |
6.054600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.474950E-01 |
| Obese-vs-Extreme_Obese |
3.588600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.002440E-01 |
| Normal-vs-Age(41-60Yrs) |
2.414400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.27760000000021E-05 |
| Normal-vs-Age(81-100Yrs) |
1.292640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.843600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.481800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.391800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.456400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.912000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.355000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.12240000005315E-06 |
| Normal-VS-Type2 PRCC |
2.783600E-02 |
| Normal-VS-KIRP CIMP |
3.517600E-01 |
| Normal-VS-Unclassified PRCC |
1.080600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.384000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.479800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.320000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.611400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.214200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.412640E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.390480E-02 |
| Normal-vs-N1 |
1.412000E-01 |
| Normal-vs-N2 |
2.338000E-01 |
| N0-vs-N1 |
5.977800E-01 |
| N0-vs-N2 |
9.879800E-01 |
| N1-vs-N2 |
8.272200E-01 |
|
|
